Search Within

Laura Hong Tang

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (80)
  2. Meeting Abstract (48)
  3. Conference Paper (2)
  4. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (131)
  2. Epidemiology and Biostatistics (131)
  3. Biostatistics Service (117)
  4. Center for Pancreatic Cancer Research (114)
  5. Department of Medicine (102)
  6. Solid Tumor Oncology Division (95)

More Groups

People
  1. Mithat Gonen (56)
  2. Yelena Janjigian (52)
  3. Daniel Coit (46)
  4. Marinela Capanu (43)
  5. Vivian Strong (42)
  6. Geoffrey Ku (37)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (16)
  4. 2022 (12)
  5. 2021 (10)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Annals of Surgical Oncology (24)
  3. Annals of Surgery (15)
  4. Pancreas (6)
  5. Clinical Cancer Research (4)
  6. American Journal of Surgical Pathology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (32)
  2. Springer (29)
  3. Lippincott Williams & Wilkins (25)
  4. Elsevier Inc. (9)
  5. Nature Publishing Group (7)
  6. American Association for Cancer Research (6)

More Publishers

Results (131)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Post-treatment/pre-operative PET response is not an independent predictor of outcomes for patients with gastric and GEJ adenocarcinoma
    Journal Article

    Hernandez, J. M.; Beylergil, V.; Goldman, D. A.; van Beek, E.; Gonen, M.; Tang, L.; Downey, R.; Rizk, N.; Shah, M.; Strong, V.; more...
    Annals of Surgery (2018)

    Fulltext@MSK | Save
  • Relevance of serum chromogranin A as diagnostic and prognostic marker for well-differentiated pancreatic neuroendocrine tumors
    Meeting Abstract

    Pulvirenti, A.; Rao, D.; Tang, L.; Gonen, M.; Fleisher, M.; Reidy-Lagunes, D.; Allen, P.
    Pancreas (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
    Journal Article

    Lowery, M. A.; Kelsen, D. P.; Capanu, M.; Smith, S. C.; Lee, J. W.; Stadler, Z. K.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical and genomic alterations features of patients with advanced colitis associated cancers (CAC)
    Meeting Abstract

    Kelsen, D. P.; Miller, V. A.; Tang, L. H.; Capanu, M.; Balasubramanian, S.; Ross, J. S.; Stephens, P. J.; Yaeger, R.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of LEE011 in combination with everolimus in the treatment of advanced well differentiated neuroendocrine tumors of foregut origin
    Meeting Abstract

    Raj, N.; Chan, J.; Dasari, A.; Capanu, M.; Tang, L.; Reidy-Lagunes, D.
    Pancreas (2017)

    Fulltext@MSK | Save
  • Integrated genomic characterization of oesophageal carcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2017)

    Fulltext@MSK | Save
  • Treatment response and outcomes of grade 3 pancreatic neuroendocrine neoplasms based on morphology: Well differentiated versus poorly differentiated
    Journal Article

    Raj, N.; Valentino, E.; Capanu, M.; Tang, L. H.; Basturk, O.; Untch, B. R.; Allen, P. J.; Klimstra, D. S.; Reidy-Lagunes, D.
    Pancreas (2017)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save